3 completed, 1 active not recruiting, 1 recruiting. 5 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Active not recruiting 1, Recruiting 1 |
| Phase 1 | 2 | Active not recruiting 1, Completed 1 |
Follow Hepatic Cancer: new trials by email Literature Review of Hepatic Cancer trials Research Report on Hepatic Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effective Dose and Safety of Esketamine During Ultrasound-guided Hepatic Tumor Thermal Ablation Intravenous esketamine using Dixon's up-and-down sequential method, Intravenous the dose of esketamine ED95, Intravenous fentanyl 1 μg∙kg-1 - Hepatic Neoplasm, Hepatic Cancer | Phase 1 / Phase 2 | Active not recruiting | The First Affiliated Hospital of Xiamen University | 79 | 2025-06-29 | 2025-09-11 |
| Neoadjuvant Intra-tumor Double Immunotherapy for Hepatocellular Carcinoma. ipilimumab, pembrolizumab, durvalumab, idarubicin, bevacizumab - Hepatic Cancer, Surgery | Phase 2 | Recruiting | Second Affiliated Hospital of Guangzhou Medical University | 90 | 2024-07-01 | 2024-07-09 |
| CS1008- in Combination With Sorafenib Compared to Sorafenib Alone in Subjects With Advanced Liver Cancer CS-1008 2 mg/kg, Sorafenib, CS-1008 6/2 mg/kg - Advanced Hepatocellular Carcinoma, Liver Cancer | Phase 2 | Completed | Daiichi Sankyo | 172 | 2010-07-09 | 2021-04-08 |
| A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy FLOXURIDINE - Hepatic Cancer | Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 34 | 2003-06-01 | 2023-04-04 |
| Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy Recombinant Human Thrombopoietin - Germ Cell Tumors, Hepatic Cancer | Phase 1 / Phase 2 | Completed | St. Jude Children's Research Hospital | 40 | 2000-06-01 | 2008-04-10 |
Liver Neoplasms (5) · Carcinoma, Hepatocellular (1) · Jacobs syndrome (1) · Neoplasms (1) · Neoplasms, Germ Cell and Embryonal (1) · Neuroblastoma (1) · Osteosarcoma (1) · Pain (1) · Rhabdomyosarcoma (1) · Thrombocytopenia (1)
Digestive System Diseases (5) · Digestive System Neoplasms (5) · Liver Diseases (5) · Neoplasms by Site (5) · Neoplasms (4) · Neoplasms by Histologic Type (2) · Neoplasms, Glandular and Epithelial (2) · Adenocarcinoma (1) · Blood Platelet Disorders (1) · Carcinoma (1) · Cytopenia (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Myosarcoma (1) · Neoplasms, Bone Tissue (1)
Bevacizumab (1) · Floxuridine (1) · Idarubicin (1) · Ipilimumab (1) · Lidocaine (1) · Sorafenib (1) · Thrombopoietin (1) · durvalumab (1) · pembrolizumab (1) · tigatuzumab (1)
Daiichi Sankyo (1) · Memorial Sloan Kettering Cancer Center (1) · Second Affiliated Hospital of Guangzhou Medical University (1) · St. Jude Children's Research Hospital (1) · The First Affiliated Hospital of Xiamen University (1)
United States (3) · China (2) · Japan (1) · South Korea (1) · Taiwan (1)
Lijuan Yan (1) · Najat C. Daw, M.D. (1) · William Jarnagin, MD (1) · Zhenfeng Zhang, MD, PhD (1)